Patent Assignment
Reel/Frame 046406/0881
Merger and Change of Name
Recorded: 2018-06-21
Pages: 3
Assignors
PROTIVA BIOTHERAPEUTICS INC.
Executed: 2018-01-01
ARBUTUS BIOPHARMA CORPORATION
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Dec 5, 2016
From: TEKMIRA PHARMACEUTICALS CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 040531/0005 →
Assignment of Assignor's Interest
Dec 5, 2016
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 040531/0036 →
Assignment of Assignor's Interest
Dec 5, 2016
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 040531/0055 →
Assignment of Assignor's Interest
Dec 5, 2016
From: FITZGERALD, KEVIN; AKINC, AKIN; MAIER, MARTIN A.; FRANK-KAMENETSKY, MARIA
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 040819/0004 →
Merger and Change of Name
Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →